Lifeward Appoints Almog Adar as CFO in Key Finance Leadership Move
ByAinvest
Wednesday, Aug 13, 2025 8:42 am ET2min read
LFWD--
Adar’s appointment comes as Lifeward’s stock price rises 4.12% premarket to $0.735, indicating investor confidence in the company's strategic direction and financial performance. Adar holds a Bachelor of Arts degree in Accounting and Economics from the Open University of Israel and is a Certified Public Accountant licensed by the Israeli Ministry of Justice. His expertise in auditing, financial reporting, and global business operations will be instrumental in driving Lifeward’s growth and strengthening its financial foundation.
Lifeward designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery. The company’s mission is to relentlessly drive innovation to change the lives of individuals with physical limitations or disabilities. The Lifeward portfolio features innovative products including the ReWalk Exoskeleton, the AlterG Anti-Gravity system, the MyoCycle FES System, and the ReStore Exo-Suit. Founded in 2001, Lifeward has operations in the United States, Israel, and Germany.
Adar’s appointment follows the recent announcement of Mark Grant as the company’s President and Chief Executive Officer. Grant stated, "I am thrilled to welcome Almog to the executive leadership team. He has been an invaluable leader within our finance team and brings thoughtful leadership and a strong commitment to supporting Lifeward’s growth.”
Adar expressed his excitement about the new role, stating, "I am honored to step into the role of Chief Financial Officer at this pivotal moment for Lifeward. We have a tremendous opportunity ahead to build on our strengths, sharpen our execution, and accelerate growth. I am committed to working closely with our leadership team to deliver a clear, disciplined strategy, strengthen our financial foundation, and create lasting value for our patients, customers, and shareholders.”
The appointment of Adar as CFO underscores Lifeward’s commitment to financial stability and growth, positioning the company to continue its innovative work in medical technology. Investors can expect Adar to bring his extensive financial expertise to Lifeward, contributing to the company’s long-term success.
References
[1] https://finance.yahoo.com/news/lifeward-names-almog-adar-cfo-120000943.html
[2] https://seekingalpha.com/news/4484592-lifeward-appoints-almog-adar-as-cfo
Lifeward has appointed Almog Adar as its new CFO, effective immediately. Adar previously served as the company's vice president of finance and chief accounting officer, joining Lifeward in 2020 as director of finance and corporate financial controller. Prior to Lifeward, Adar worked as Controller of Infinya Recycling. The appointment comes as Lifeward's stock price rises 4.12% premarket to $0.735.
Lifeward Ltd. (Nasdaq: LFWD), a global leader in innovative medical technology, has appointed Almog Adar as its new Chief Financial Officer (CFO), effective immediately. Adar joins the executive leadership team from his previous role as Vice President of Finance and Chief Accounting Officer at Lifeward, where he played a key role in shaping the company’s financial strategy and supporting its growth. Prior to Lifeward, Adar served as Controller of Infinya Recycling Ltd. and as Assistant Controller at Delta Galil Industries, gaining extensive experience in complex financial management and global business operations.Adar’s appointment comes as Lifeward’s stock price rises 4.12% premarket to $0.735, indicating investor confidence in the company's strategic direction and financial performance. Adar holds a Bachelor of Arts degree in Accounting and Economics from the Open University of Israel and is a Certified Public Accountant licensed by the Israeli Ministry of Justice. His expertise in auditing, financial reporting, and global business operations will be instrumental in driving Lifeward’s growth and strengthening its financial foundation.
Lifeward designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery. The company’s mission is to relentlessly drive innovation to change the lives of individuals with physical limitations or disabilities. The Lifeward portfolio features innovative products including the ReWalk Exoskeleton, the AlterG Anti-Gravity system, the MyoCycle FES System, and the ReStore Exo-Suit. Founded in 2001, Lifeward has operations in the United States, Israel, and Germany.
Adar’s appointment follows the recent announcement of Mark Grant as the company’s President and Chief Executive Officer. Grant stated, "I am thrilled to welcome Almog to the executive leadership team. He has been an invaluable leader within our finance team and brings thoughtful leadership and a strong commitment to supporting Lifeward’s growth.”
Adar expressed his excitement about the new role, stating, "I am honored to step into the role of Chief Financial Officer at this pivotal moment for Lifeward. We have a tremendous opportunity ahead to build on our strengths, sharpen our execution, and accelerate growth. I am committed to working closely with our leadership team to deliver a clear, disciplined strategy, strengthen our financial foundation, and create lasting value for our patients, customers, and shareholders.”
The appointment of Adar as CFO underscores Lifeward’s commitment to financial stability and growth, positioning the company to continue its innovative work in medical technology. Investors can expect Adar to bring his extensive financial expertise to Lifeward, contributing to the company’s long-term success.
References
[1] https://finance.yahoo.com/news/lifeward-names-almog-adar-cfo-120000943.html
[2] https://seekingalpha.com/news/4484592-lifeward-appoints-almog-adar-as-cfo

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet